Research on CAR T Therapy in Earlier Lines of Treatment
Amit Patel, BSc, MBBS, PhD, discusses currently ongoing clinical trials of CAR T-cell therapy in first- and second-line treatment settings and comments on potential developments on the horizon.
Optimizing Patient Selection for CAR T-Cell Therapy
A key opinion leader in hematology and oncology shares insights on factors to consider for optimal patient selection and treatment sequencing, such as thresholds for tolerability, renal function, and cardiac ejection fraction.
2 Commerce Drive Cranbury, NJ 08512